Based on these results, we propose that OA-NO2 and Nrf2 may alleviate vasoconstrictive effects of ET-1 by removing it from the circulation.
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Introduction
Nitro-fatty acids are endogenous signaling molecules formed in vivo when unsaturated fatty acids react with nitric oxide and nitric oxide derived species . Nitro-fatty acids are generated in inflammatory conditions including ischemic preconditioning (Nadtochiy et al., 2009 ) and myocardial ischemia/reperfusion . Nitro-fatty acids can alter specific signaling pathways by Michael addition with nucleophiles of biological targets. They can modulate regulatory protein functions via post-translational modification of susceptible nucleophilic amino acids, such as cysteines (Cys) Baker et al., 2007; Schopfer et al., 2010; Kansanen et al., 2011) . Nitro-oleic acid (OA-NO2) is beneficial in murine models of vascular disease (Cole et al., 2009; , type 2 diabetes , and both myocardial and renal (Wang et al., 2010) ischemia reperfusion injury. In addition, OA-NO2 has antihypertensive effects in AngII induced mouse hypertension , and it also has antihypertensive signaling actions via inhibition of the enzymatic activity of epoxyeicosatrienoic acid (EET) hydrolyzing soluble epoxide hydrolase by adduction to Cys521 in the vicinity of its catalytic center (Charles et al., 2014) .
Nuclear factor-E2-related factor 2 (Nrf2) is a transcription factor that regulates a multiple antioxidant and cytoprotective genes. The well-known Nrf2 target genes that are often used as markers for Nrf2 activation are heme oxygenase-1 (HMOX1), glutamate-cysteine ligase (GCL) and NAD(P)H quinone oxidoreductase-1 (Kwak et al., 2003; Lee et al., 2003) . Kelch-like ECHassociated protein 1 (Keap1) is a redox-regulated protein that inhibits the nuclear translocation of Nrf2 by mediating the rapid ubiquitination and degradation of Nrf2 in non-stimulated, basal conditions (Zhang and Hannink, 2003) . In oxidative or electrophilic stress, specific Cys residues in Keap1 are modified, which results in conformational change in Keap1 leading to the escape of Nrf2 from the Keap1-dependent degradation pathway and translocation to the nucleus. In the nucleus, Nrf2 binds to the Antioxidant Response Element (ARE) located in the This article has not been copyedited and formatted. The final version may differ from this version. 
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5 enhancer region of its target genes thus driving their expression (Kansanen et al., 2012) . We have previously discovered that OA-NO2 induces Nrf2-dependent cytoprotective gene expression (Kansanen et al., 2009) , which involves direct modification of Keap1 Cys residues Cys38, Cys226, Cys257, Cys273, Cys288, and Cys489. Of these Keap1 cysteine residues, Cys273, Cys288 were found to be functionally most important in the activation of Nrf2 (Kansanen et al., 2011) . Furthermore, in a genome-wide analysis of Nrf2-dependent and independent effects of OA-NO2, we found that the expression of endothelin receptor B (ET-B, gene name EDNRB) was induced by OA-NO2 and repressed by Nrf2 siRNA in human endothelial cells (Kansanen et al., 2009) . ET-B is a receptor for endothelin-1 (ET-1, gene name EDN1), which was first identified as a potent vasoconstrictor, but it is now recognized that ET-1 can also function as a vasodilator depending on the receptor being activated. In the vasculature, endothelin receptor A (ET-A, gene name EDNRA) is present predominantly in smooth muscle cells, whereas the ET-B receptor is located in endothelial cells. However, a sub-family of ET-B receptors is also present in vascular smooth muscle cells. In smooth muscle cells, activation of both ET-A and ET-B induces vasoconstriction, but the stimulation of ET-B receptors in endothelial cells promote vasodilatation (Schneider et al., 2007) . In addition, ET-B functions as a clearance receptor to remove ET-1 from the circulation (Kelland, Bagnall, et al., 2010) .
Inasmuch as ET-1 is one of the key regulators of vascular tone, we chose to examine in more detail the effect of OA-NO2 on endothelin signaling in human endothelial cells. We show that the upregulation of ET-B receptor by OA-NO2 is tightly regulated by Nrf2 in human and mouse endothelial cells. In addition, in silico screening identified two putative ARE sites residing on the active enhancer region at the EDNRB gene locus. In response to OA-NO2, ChIP analysis revealed an increase in binding of Nrf2 to an ARE site located 5253 base pairs upstream of transcription start site of EDNRB gene. In addition, we show that both OA-NO2 and Nrf2 overexpression substantially decreased, and Nrf2 silencing increased the ET-1 concentration in the cell culture media. The decrease in the extracellular ET-1 concentration was dependent This article has not been copyedited and formatted. The final version may differ from this version. 
6 on ET-B receptor expression. These data suggest that Nrf2 regulates the OA-NO2 induced transcription of ET-B, which may lead to clearance of ET-1 from the circulation.
Materials and Methods
Reagents − OA-NO2 was prepared as previously described . The synthetic nitration product used in the study was an equimolar mixture of 9-and 10-nitrooctadec-9-enoic acid. BQ-788 was from Sigma (St. Louis, MO, USA).
Cell culture − Human umbilical vein endothelial cells (HUVECs) were isolated from umbilical cords obtained from the maternity ward of the Kuopio University Hospital by the approval of the Kuopio University Hospital Ethics Committee. Each mother signed an informed consent.
HUVECs were cultured as previously published (Levonen et al., 2004) . Cells from multiple donors were used for experiments at cell passages 4-6. Human aortic endothelial cells (HAECs) were obtained from Lonza (Bergisch Gladbach, Germany) and cultured as in (Kivelä et al., 2010) . Cells from a single donor were used at passages 8-10. Human aortic smooth muscle cells (HASMC) were purchased from Cascade Biologics (Portland, OR) and cultured in 231 medium supplemented with Smooth Muscle Cell Growth Supplement (Cascade Biologics, Portland, OR). Cells were from a single donor and used at passages 10-12. Mouse endothelial cells were isolated as described (Zhang et al., 2009) , with modifications. The lungs and hearts from 10 week-old wild type or Nrf2 knock out mice were removed under surgical anesthesia and collected in a tube containing cold base medium (DMEM with 20% FBS, 20 mM HEPES and 50 U/ml penicillin, 50 μg/ml streptomycin). Tissues were washed with 1xPBS and finely minced and digested using type II collagenase (Worthington Biochemical Corp, Lakewood, NJ) for 1 h at 37°C with gentle agitation. Digested tissues were passed through a 20-gauge needle 10-15 times and were then filtered through a 70-μm cell strainer. The digested filtrate was centrifuged, and the pellet was washed twice and resuspended in base This article has not been copyedited and formatted. The final version may differ from this version. antibody (BD Pharmingen, Minneapolis, MN) after which 100 µl of magnetic microbeads (Miltenyi Biotech, Bergisch Gladbach, Germany) were added to the mixture and incubated at RT for 15 min. Cells with beads attached were collected using an MACS separation columns (Miltenyi Biotech, Bergisch Gladbach, Germany) and washed 3 times with PBS. Washed cells were collected and plated in full medium (base medium with 1/100 NEAA, 1/100 Sodium Pyruvate, 1 mM L-glutamine, 0.1 mg/ml Endothelial mitogen, 0.1 mg/ml Heparin) tissue culture plates that had been precoated with 10 µg/ml Fibronectin (Sigma, St. Louis, MO, USA) in PBS.
After 24h, nonattached cells and excess beads were removed, and fresh medium was added. Western blot -HUVECs and HAECs were treated with 5 µM OA-NO2 for 2 or 4h after which cells were collected to MNase buffer (10 mM Tris pH 7.4, 10 mM NaCl, 5 mM MgCl2, 0.1 % NP-40, protease inhibitors) to extract the nuclear fraction. The extracted nuclei were lysed and the nuclear proteins were electrophoresed on a Tris/glycine SDS-polyacrylamide gel and transferred to nitrocellulose membrane. The primary antibodies used for detection were rabbit polyclonal anti-Nrf2 (Santa Cruz Biotechnology), rabbit polyclonal anti-Lamin B1 (Abcam).
Blots were visualized using Cy5-conjugated secondary antibodies with ChemiDoc (BioRad) scanner. Protein expression was quantified with ImageLab Software (Version 5.2.1 BioRad). Adenoviral overexpression -Cloning and production of AdNrf2 (Nrf2-overexpressing adenovirus) were performed as described previously (Levonen et al., 2007) . Multiplicity of infection (MOI) of 100 was used for experiments. using specific assays-on-demand (Applied Biosystems, Foster City, CA) target mixes. The expression levels were normalized to β2-microglobulin or to GAPDH expression and presented as fold change in the expression versus control.
RNA isolation and qPCR −
Chromatin immonoprecipitation (ChIP) -. ChIP analysis was done as previously described (Kansanen et al., 2011) . Briefly, HUVECs were treated with 5 µM OA-NO2 for 30 min to 2 h. Nuclear proteins were cross-linked to DNA by adding formaldehyde directly to the medium to a final concentration of 1% for 10 min at RT on a rocking platform. Cross-linking was stopped by adding glycine to a final concentration of 0.125 M for 5 min at RT on a rocking platform.
Nuclei were extracted by scraping the cells to 1 ml of MNase buffer (10 mM Tris pH 7.4, 10 mM NaCl, 5 mM MgCl2, 0,1 % NP-40, protease inhibitors. The extracted nuclei were lysed with 0.3 ml SDS lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris-HCl, pH 8.1, protease inhibitors 
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9 Triton X-100, 1.2 mM EDTA, 167 mM NaCl, 16.7 mM Tris-HCl, pH 8.1, protease inhibitors).
2.5 µl BSA (100 mg/ml) was added to each tube. 100 μl the chromatin sample was removed as input DNA and stored at + 4 C until Proteinase K treatment and purification. 100 μl of antibody-bound (Nrf2, sc-722, and anti-rabbit IgG, Sc-2027, Santa Cruz Biotechnologies)
Magna ChIP magnetic beads (Millipore) were added to the chromatin samples and the samples were incubated O/N at + 4 C on a rocking platform. Next day, the beads were separated with a magnetic rack and washed five times with LiCl wash buffer (100 mM Tris pH 7.5, 500 mM LiCl, 1 % IGEPAL, 1 % Sodium deoxycholate) and twice with TE buffer (10 mM Tris-HCl, pH 7.5, 1 mM EDTA). For elution, 200 μl of elution buffer (1 % SDS, 0.1 M NaHCO3) was added to the beads and the mixture was incubated at RT for 1 h with vortexing the beads every 15
min. 100 μl of elution buffer was added to input sample. 2 μl of Proteinase-K (10 mg/ml, Thermo Scientific) was added to all samples and the samples were incubated at + 65 C O/N. Next day, DNA was purified with MinElute PCR Purification Kit (Qiagen, Hilden, Germany). This article has not been copyedited and formatted. The final version may differ from this version. 
Results
Previously, we studied Nrf2-dependent and independent effects of OA-NO2 in human endothelial cells using a genome-wide expression analysis. The data indicated that OA-NO2 upregulated ET-B receptor mRNA expression in an Nrf2-dependent manner (Kansanen et al., 2009 ). To verify this finding, human umbilical vein endothelial cells (HUVEC) were treated with OA-NO2 and the ET-B receptor mRNA expression was measured with quantitative PCR.
HMOX1 and GCLM, genes that are well known to be induced in response to OA-NO2 treatment (Kansanen et al., 2009) , were used as a positive controls. OA-NO2 increased both HMOX1 ( (Schneider et al., 2007) .
We compared the OA-NO2 induced ET-B expression both in HUVECs and in human smooth
This article has not been copyedited and formatted. The final version may differ from this version. (Figure 2A ). In HUVECs 2.5 µM OA-NO2
induced ET-R receptor expression by 6.2-fold and 5 µM OA-NO2 by 4.6-fold. In HASMCs the fold induction after 2.5 and 5 µM OA-NO2 were 2.0 and 2.6, respectively. The difference between the fold changes shown in Figure 1 and Figure 2 is likely because of donor-specific differences in HUVEC isolations. Furthermore, OA-NO2 did not increase the expression of ET-A receptor in HASMCs, and HUVECs did not express any detectable ET-A mRNA ( Figure 2B ).
In comparison, OA-NO2 induced the expression of Nrf2 target genes HMOX1 and GCLM in both HUVECs and HASMC. HMOX1 expression was higher in HASMC ( Figure 2C ), and there was no difference in GCLM mRNA expression when the two cell lines were compared ( Figure   2D ). To study whether the higher ET-B receptor expression in HUVECs was due to the higher expression of Nrf2, both mRNA expression and nuclear Nrf2 translocation were measured.
Nrf2 mRNA expression was higher in HASMC, but the difference was significant only in basal condition ( Figure 2E ). As Nrf2 activation is mainly regulated at the post-transcriptional level (Suzuki and Yamamoto, 2015) , nuclear translocation of Nrf2 after OA-NO2 treatment was measured. OA-NO2 increased the nuclear accumulation of Nrf2 in both cell lines, and the accumulation was more pronounced in HAECs ( Figure 2F-G) . Thus, the lower ET-B induction in response to OA-NO2 is not due to lower Nrf2 expression, suggesting an alternative mechanism for more pronounced ET-B receptor expression in HUVECs.
To study whether Nrf2 mediates the OA-NO2 induced upregulation of ET-B, the effect of Nrf2 overexpression was studied first. In HUVECs, overexpression of Nrf2 by adenovirus (AdNrf2, Figure 3A ) resulted in a robust induction in ET-B mRNA ( Figure 3B ). Next, the role of Nrf2 Figure 4D ). The binding of Nrf2 to the distal enhancer region in HMOX1 gene was used as a positive control (Kansanen et al., 2011) ( Figure 4F ).
The function of the ET-B receptor is to mediate the vasodilatory effects of ET-1, and it also functions as a decoy receptor to clear ET-1 from the circulation (Kelland, Kuc, et al., 2010) . To study the functional effect of OA-NO2 and Nrf2 induced ET-B expression, ET-1 peptide concentration was measured from the cell culture medium. OA-NO2 was found to significantly decrease ET-1 concentration in the medium by 4h after addition of OA-NO2 ( Figure 5A ). After
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13 24 h, the ET-1 concentration was reduced by 41% ( Figure 5B ). In addition, overexpression of Nrf2 ( Figure 3A ) decreased the amount of ET-1 detectable in the medium by 79% ( Figure 5C ), and Nrf2 silencing ( Figure 3C ) increased ET-1 concentration by 20% ( Figure 5D ). To investigate whether the change in extracellular ET-1 concentration was due to the transcriptional repression of ET-1 gene, EDN1, the mRNA expression of EDN1 was measured.
In contrast to ET-B receptor mRNA ( Figure 5I-L Figure 5H and Figure 6C ). When ET-B receptor was blocked with BQ-788, the siNrf2-induced increase in ET-1 concentration was reduced from 2.2x to 1.7x, further confirming that OA-NO2 and Nrf2 modulate the ET-B dependent clearance of ET-1 from the extracellular compartment.
Because ET-B receptor transcription is stringently regulated by Nrf2 ( Figure 3C-E) , the effect of Nrf2 silencing on OA-NO2 induced ET-1 clearance was also examined. As expected, in nontreated conditions, Nrf2 silencing significantly increased and OA-NO2 treatment decreased the amount of ET-1 by 61% in the cell culture medium ( Figure 6D ). However, when Nrf2 was silenced OA-NO2 treatment decreased the ET-1 concentration even further (by 70%). At the same time, in control condition, siNrf2 increased the amount of ET-1 in the cell culture medium by 1.5x, but in OA-NO2 treated cells, the increase was only 1.2x and did not reach statistical 
Discussion
In this study, we show for the first time that OA-NO2 modulates the endothelin signaling by inducing Nrf2-dependent expression of ET-B receptor, thereby decreasing extracellular ET-1 secreted by cultured endothelial cells. In addition, we show that Nrf2 directly regulates the ET-B receptor gene, EDNRB, and its expression is largely dependent on this transcription factor.
Nitro-fatty acids, such as OA-NO2, are endogenous reactive lipids formed when unsaturated fatty acids react with nitric oxide or nitric oxide-derived species . In vivo, nitro-fatty acids are measured at low nM concentrations but they are robustly elevated in inflammatory conditions Salvatore et al., 2013) . The main mechanism and signaling action of OA-NO2 is via post-transcriptional modification of regulatory proteins, such as PPARγ , Keap1 (Kansanen et al., 2011) , and NF-κB (Cui et al., 2006) . Furthermore, OA-NO2 can increase NO bioavailability via endothelial NO synthase phosphorylation . OA-NO2 has shown to be beneficial in murine models of vascular disease (Cole et al., 2009; , type 2 diabetes , and both myocardial and renal (Wang et al., 2010) ischemiareperfusion injury. Furthermore, in an Ang II-induced hypertension in mice, OA-NO2 is shown to reduce blood pressure by direct adduction of the AT1 receptor . In
This article has not been copyedited and formatted. The final version may differ from this version. (Charles et al., 2014) . In this study, we show an additional potential mechanism by which OA-NO2 may reduce blood pressure. This mechanism involves Nrf2-dependent increase in ET-B receptor expression, which leads to increased clearance of ET-1. In previous studies, we have shown that OA-NO2 induces Nrf2-dependent activation via modification of Cys residues in Nrf2 inhibitor protein Keap1 (Kansanen et al., 2011) . Therefore, it can be postulated that the increase in Nrf2-dependent ET-B receptor expression is also mediated via post-translational modification of Keap1.
Endothelin-1 is a vasoactive 21 amino acid cyclic peptide, which was originally isolated from porcine aortic endothelial cells (Yanagisawa et al., 1988) . Several cell types can synthesize and release ET-1, but the most important biological source is the endothelium. ET-1 has a halflife of less than 2 minutes in blood (Dhaun et al., 2008) and it is rapidly taken up by the vasculature. The uptake involves binding of ET-1 to cell surface ET-B receptors, internalization of the ligand bound receptor, followed by receptor degradation, probably within lysosomes (Bremnes et al., 2000) . Endothelin receptors in different tissues regulate diverse physiological responses including vasoconstriction, vasodilation, clearance of ET-1, and renal sodium absorption (Schneider et al., 2007; Kohan et al., 2011) . ET-1 has been shown to play a role in high salt-induced hypertension, likely via the combined effect of impaired ET-B receptor mediated ET-1 clearance as well as the activation of the ET-A receptor (Gariepy et al., 2000; Pollock and Pollock, 2001; Amiri et al., 2010) . Therefore, the effects of selective ET-A, ET-B or dual ET-A/ET-B receptor antagonists on hypertension have been investigated. Results show that while ET-A or both ET-A and ET-B receptor inhibition with selective ET-A or dual ET-A/ET-B antagonists reduce blood pressure (Krum et al., 1998; Nakov et al., 2002) , more profound effects are achieved with ET-B blockers, which increase blood pressure (Strachan et al., 1999; Opgenorth et al., 2000) . These results suggest that the more important physiological role of ET-1. Our results are consistent with the findings that OA-NO2 has anti-hypertensive effects in mouse models of hypertension Charles et al., 2014) . Furthermore, increasing or restoring ET-B receptor function may be helpful also in other diseases where ET-1 production is increased, such as chronic kidney disease (Cottone et al., 2009) have a sustained increase in Nrf2 activity are protected against hypoxia-induced pulmonary alterations related to PAH, whereas these were aggravated in Nrf2-deficient mice (Eba et al., 2013) . Similar to genetic overexpression, the Nrf2 inducer oltipraz afforded protection against pulmonary artery muscularization in wild type but not in Nrf2-deficient mice (Eba et al., 2013) , highlighting the therapeutic potential of Nrf2 activators in the treatment of PAH.
Our results suggest that there is a cell type specific difference in the regulation of the ET-B receptor mRNA in HUVECs and HASMCs. In contrast to Nrf2 target gene and Nrf2 mRNA expression, OA-NO2 had a substantially smaller effect on ET-B receptor mRNA expression in HASMC than in HUVECs. As cell type specific gene regulation is largely regulated by epigenetic mechanisms, the different response in these cells lines may be due to difference in methylation of gene regulatory regions. Methylation of these regions renders chromatin inaccessible to binding of a given transcription factor in one cell type whereas the chromatin is maintained in an open conformation allowing transcription factor binding in another cell type (Shirodkar et al., 2013) . 
